You increase your dose, nausea appears within the first week at the new dose, it peaks around days 3 to 7, then gradually fades
Many patients combine these medications with our surgical expertise, and for those experiencing significant weight loss, we also offer body contouring procedures including tummy tuck and skin tightening to complete your transformation
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Mounjaro), chronic weight management (under the brand name Zepbound), and most recently in 2024, for the treatment of adults with moderate-to-severe obstructive sleep apnea who have obesity or are overweight with at least one weight-related comorbidity
What almost no one is talking about is what the 2025 research now shows these same medications can do for rheumatoid arthritis and why, for a carefully chosen group of patients, they may be one of the most useful additions to RA treatment weve had in years
GLP-1 drugs have helped millions of Americans lose weight and get healthier, but have also been in short supply as brand-name drugmakers struggle to meet demand